SAN DIEGO and CHICAGO – LaSalle Investment Management (“LaSalle”) announced that it has acquired partial interest in the world headquarters and life sciences campus of Illumina (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies. LaSalle made the investment on behalf of its U.S. core open-end real estate fund, LaSalle Property Fund (“LPF”) with the property’s developer, an S&P 500® U.S. equity REIT. This transaction represents LaSalle’s first investment in the life sciences property sector.
Located in the heart of the coastal infill submarket of University Town Center in San Diego, California, the Class A property consists of 793,000 square feet spread across six, state-of-the-art office, lab, and accessory buildings on 44 acres. The property is 100% occupied by Illumina and is under a long-term lease agreement serving as their world headquarters. As part of the transaction, LaSalle will be investing in the developable land on the property’s campus, allowing LPF to participate in potential future expansion and densification.
Jim Garvey, Portfolio Manager for LaSalle Property Fund, commented: “This acquisition is a strong fit for our portfolio and represents a continuation of our ability to source world-class properties that provide an attractive income return with the potential for significant appreciation. We are pleased to have entered the life sciences sector with a best-in-class partner in a leading life sciences submarket, University Town Center.”
Erick Paulson, Managing Director of Acquisitions at LaSalle, said: “We are excited to acquire this world-class property in a highly strategic location, as San Diego is one of the largest U.S. biotech hubs. The San Diego market is comprised of over 15 million square feet of life science space, supported by strong occupancy and rental fundamentals, and The University of California at San Diego registers as the single greatest source of graduates in biomedical and biological sciences in the nation.”
Steve Bolen, Head of U.S. Healthcare Real Estate at LaSalle, added: “This acquisition aligns LaSalle with a market-leading life sciences property that is uniquely positioned to thrive in the growing field of DNA sequencing and array-based technologies, serving end-users in the research, clinical and applied markets. In addition to its position as a strong life science submarket, University Town Center is widely regarded as the premier medical office submarket within San Diego, given its proximity to four of the MSA’s major hospital campuses, including UCSD Health Jacobs Medical Center, Scripps’ Memorial Hospital La Jolla, Scripps’ Green Hospital, and the VA San Diego Hospital System.
For more than 15 years, LaSalle has been one of the most active private equity investors in the medical office sector and we are excited to make our flagship investment in the life sciences field, with such a high-quality partner and irreplaceable property.”
About LaSalle Property Fund
LPF invests in and manages a diversified portfolio of high quality, stabilized real estate and real estate-related assets in the industrial, multifamily, office and retail sectors in top markets across the United States. Drawing from LaSalle Investment Management, Inc.’s 40-year record of accomplishment of core real estate investment on behalf of sophisticated institutional investors, LPF aims to provide attractive risk-adjusted income returns with the potential for superior long-term capital growth through an investment process and platform that leverages LaSalle’s industry-leading market research.
About LaSalle Investment Management
LaSalle Investment Management is one of the world’s leading real estate investment managers. On a global basis, LaSalle manages over $68 billion of assets in private and public real estate property and debt investments as of Q2 2019. LaSalle’s diverse client base includes public and private pension funds, insurance companies, governments, corporations, endowments and private individuals from across the globe. LaSalle sponsors a complete range of investment vehicles including separate accounts, open- and closed-end funds, public securities and entity-level investments. For more information please visit http://www.lasalle.com, and LinkedIn.
The information discussed above is based on the market analysis and expectations of LaSalle and should not be relied upon by the reader as research or investment advice regarding LaSalle funds or any issuer or security in particular. The information presented herein is for illustrative and educational purposes and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy in any jurisdiction where prohibited by law or where contrary to local law or regulation. Any such offer to invest, if made, will only be made to certain qualified investors by means of a private placement memorandum or applicable offering document and in accordance with applicable laws and regulations. Past performance is not indicative of future results, nor should any statements herein be construed as a prediction or guarantee of future results.
Megan Kivlehan, Vice President
D 646-677-1807 Norwalk, CT
The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE